Endobronchial obstruction in connective tissue diseases: an uncommon but life threatening complication: two case reports.


Journal

Journal of medical case reports
ISSN: 1752-1947
Titre abrégé: J Med Case Rep
Pays: England
ID NLM: 101293382

Informations de publication

Date de publication:
02 Aug 2023
Historique:
received: 06 03 2023
accepted: 24 06 2023
medline: 3 8 2023
pubmed: 2 8 2023
entrez: 1 8 2023
Statut: epublish

Résumé

Granulomatosis with polyangiitis and relapsing polychondritis are rare, multisystemic and potentially life-threatening connective tissue diseases. We present two cases of severe endobronchial obstruction in the aforementioned conditions and discuss difficulties with detection and treatment. Despite differing underlying pathophysiologies, endobronchial disease is a less frequently reported but serious complication of both conditions. Case 1, a 31-year-old South Asian woman with relapsing polychondritis, required partial tracheal resection and reconstruction in combination with immunosuppressive therapy to achieve respiratory recovery following collapse of her right main bronchus and a stricture in her left main bronchus. Case 2, a 22-year-old Caucasian male with granulomatosis with polyangiitis, underwent surgical resection of an endobronchial growth causing occlusion of his right main bronchus. Although his respiratory status was initially stabilised with increased immunosuppression, he continues to have disease progression in spite of this. Our cases highlight the importance of a multidisciplinary approach combining immunosuppression with supportive care and judicious use of surgical interventions in select cases. A further review of the literature shows endobronchial obstruction is potentially under-reported due to overlap in connective tissue disease symptomatology and there is no consensus on best practice.

Sections du résumé

BACKGROUND BACKGROUND
Granulomatosis with polyangiitis and relapsing polychondritis are rare, multisystemic and potentially life-threatening connective tissue diseases. We present two cases of severe endobronchial obstruction in the aforementioned conditions and discuss difficulties with detection and treatment. Despite differing underlying pathophysiologies, endobronchial disease is a less frequently reported but serious complication of both conditions.
CASE PRESENTATION METHODS
Case 1, a 31-year-old South Asian woman with relapsing polychondritis, required partial tracheal resection and reconstruction in combination with immunosuppressive therapy to achieve respiratory recovery following collapse of her right main bronchus and a stricture in her left main bronchus. Case 2, a 22-year-old Caucasian male with granulomatosis with polyangiitis, underwent surgical resection of an endobronchial growth causing occlusion of his right main bronchus. Although his respiratory status was initially stabilised with increased immunosuppression, he continues to have disease progression in spite of this.
CONCLUSIONS CONCLUSIONS
Our cases highlight the importance of a multidisciplinary approach combining immunosuppression with supportive care and judicious use of surgical interventions in select cases. A further review of the literature shows endobronchial obstruction is potentially under-reported due to overlap in connective tissue disease symptomatology and there is no consensus on best practice.

Identifiants

pubmed: 37528419
doi: 10.1186/s13256-023-04058-x
pii: 10.1186/s13256-023-04058-x
pmc: PMC10394769
doi:

Types de publication

Review Case Reports Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

329

Informations de copyright

© 2023. The Author(s).

Références

Orphanet J Rare Dis. 2021 May 17;16(1):225
pubmed: 34001193
Clin Rheumatol. 2013 Nov;32(11):1575-83
pubmed: 23887438
Chest. 2022 Jan;161(1):257-265
pubmed: 34324839
Cleve Clin J Med. 2012 Nov;79 Suppl 3:S16-21
pubmed: 23203639
Rheumatology (Oxford). 2020 Jan 1;59(1):99-106
pubmed: 31236569
JAMA Otolaryngol Head Neck Surg. 2014 Nov;140(11):1038-44
pubmed: 25321076
Respirol Case Rep. 2019 Nov 12;8(1):e00501
pubmed: 31741739
Rheumatology (Oxford). 2019 Dec 1;58(12):2203-2211
pubmed: 31199488
Semin Arthritis Rheum. 2019 Feb;48(4):714-719
pubmed: 29891418

Auteurs

Rushab Shah (R)

Department of Rheumatology, St Vincent's Hospital (Melbourne), 41 Victoria Parade, Fitzroy, VIC, 3065, Australia.

Lisa Lim (L)

Department of Rheumatology, St Vincent's Hospital (Melbourne), 41 Victoria Parade, Fitzroy, VIC, 3065, Australia.

Mandana Nikpour (M)

Department of Rheumatology, St Vincent's Hospital (Melbourne), 41 Victoria Parade, Fitzroy, VIC, 3065, Australia. m.nikpour@unimelb.edu.au.
The University of Melbourne at St Vincent's Hospital (Melbourne), 41 Victoria Parade, Fitzroy, VIC, 3065, Australia. m.nikpour@unimelb.edu.au.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH